Yiman Feng
Biographic Data
| ID | 10021283 |
|---|---|
| NAME | Yiman Feng |
| GIVEN NAMES | Yiman |
| FAMILY NAME | Feng |
| SIGNATURE | FENG Y |
| AFFILIATIONS | China Pharmaceutical University |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
Objective This study aimed to assess whether different clinical trial endpoints in pivotal trials of cancer drugs were associated with reimbursement decisions in China. Materials and methods Cancer drugs marketed before June 30 th , 2021 with publicly available technical review reports for application of drug registration on Center for Drug Evaluation (CDE) website were reviewed. The trial design characteristics and relevant clinical outcomes [e.…
No prominent works on this page.
Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
Objective This study aimed to assess whether different clinical trial endpoints in pivotal trials of cancer drugs were associated with reimbursement decisions in China. Materials and methods Cancer drugs marketed before June 30 th , 2021 with publicly available technical review reports for application of drug registration on Center for Drug Evaluation (CDE) website were reviewed. The trial design characteristics and relevant clinical outcomes [e.…
Actuarial science (1 work) · Business (1 work) · Cancer (1 work) · Cancer drugs (1 work) · China (1 work) · Clinical trial (1 work) · Economic and Financial Impacts of Cancer (1 work) · Family medicine (1 work) · Health care (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work)